JP5889910B2 - 新規セレンテラジン基質及び使用法 - Google Patents

新規セレンテラジン基質及び使用法 Download PDF

Info

Publication number
JP5889910B2
JP5889910B2 JP2013537799A JP2013537799A JP5889910B2 JP 5889910 B2 JP5889910 B2 JP 5889910B2 JP 2013537799 A JP2013537799 A JP 2013537799A JP 2013537799 A JP2013537799 A JP 2013537799A JP 5889910 B2 JP5889910 B2 JP 5889910B2
Authority
JP
Japan
Prior art keywords
pbi
coelenterazine
ogluc
luminescence
luciferase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013537799A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503485A (ja
Inventor
ディーター エイチ クラウバート
ディーター エイチ クラウバート
ポンチョ マイゼンハイマー
ポンチョ マイゼンハイマー
ジェームズ アンク
ジェームズ アンク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Promega Corp
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44983728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5889910(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Promega Corp filed Critical Promega Corp
Publication of JP2014503485A publication Critical patent/JP2014503485A/ja
Application granted granted Critical
Publication of JP5889910B2 publication Critical patent/JP5889910B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C12Y113/12005—Renilla-luciferin 2-monooxygenase (1.13.12.5), i.e. renilla-luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C12Y113/12007—Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C12Y113/12013—Oplophorus-luciferin 2-monooxygenase (1.13.12.13)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2013537799A 2010-11-02 2011-11-02 新規セレンテラジン基質及び使用法 Active JP5889910B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40942210P 2010-11-02 2010-11-02
US61/409,422 2010-11-02
PCT/US2011/059017 WO2012061529A1 (en) 2010-11-02 2011-11-02 Novel coelenterazine substrates and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016028303A Division JP6574721B2 (ja) 2010-11-02 2016-02-17 新規セレンテラジン基質及び使用法

Publications (2)

Publication Number Publication Date
JP2014503485A JP2014503485A (ja) 2014-02-13
JP5889910B2 true JP5889910B2 (ja) 2016-03-22

Family

ID=44983728

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2013537799A Active JP5889910B2 (ja) 2010-11-02 2011-11-02 新規セレンテラジン基質及び使用法
JP2013537800A Active JP6155424B2 (ja) 2010-11-02 2011-11-02 オキヒオドシエビ属由来ルシフェラーゼ、新規セレンテラジン基質、及び使用法
JP2016024952A Active JP6374420B2 (ja) 2010-11-02 2016-02-12 オキヒオドシエビ属由来ルシフェラーゼ、新規セレンテラジン基質、及び使用法
JP2016028303A Active JP6574721B2 (ja) 2010-11-02 2016-02-17 新規セレンテラジン基質及び使用法
JP2017084390A Active JP6539689B2 (ja) 2010-11-02 2017-04-21 オキヒオドシエビ属由来ルシフェラーゼ、新規セレンテラジン基質、及び使用法
JP2018040100A Active JP6752839B2 (ja) 2010-11-02 2018-03-06 新規セレンテラジン基質及び使用法

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2013537800A Active JP6155424B2 (ja) 2010-11-02 2011-11-02 オキヒオドシエビ属由来ルシフェラーゼ、新規セレンテラジン基質、及び使用法
JP2016024952A Active JP6374420B2 (ja) 2010-11-02 2016-02-12 オキヒオドシエビ属由来ルシフェラーゼ、新規セレンテラジン基質、及び使用法
JP2016028303A Active JP6574721B2 (ja) 2010-11-02 2016-02-17 新規セレンテラジン基質及び使用法
JP2017084390A Active JP6539689B2 (ja) 2010-11-02 2017-04-21 オキヒオドシエビ属由来ルシフェラーゼ、新規セレンテラジン基質、及び使用法
JP2018040100A Active JP6752839B2 (ja) 2010-11-02 2018-03-06 新規セレンテラジン基質及び使用法

Country Status (15)

Country Link
US (11) US8809529B2 (enExample)
EP (4) EP3498710A1 (enExample)
JP (6) JP5889910B2 (enExample)
KR (2) KR101939553B1 (enExample)
CN (3) CN103370319B (enExample)
AU (2) AU2011323418B2 (enExample)
BR (2) BR112013010855A2 (enExample)
CA (3) CA2815227C (enExample)
DK (2) DK2635582T3 (enExample)
ES (2) ES2567410T3 (enExample)
IL (5) IL225867B (enExample)
PL (2) PL2635595T3 (enExample)
PT (1) PT2635595T (enExample)
SG (5) SG10202103336SA (enExample)
WO (2) WO2012061529A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018127459A (ja) * 2010-11-02 2018-08-16 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 新規セレンテラジン基質及び使用法

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005038029A2 (en) 2003-10-10 2005-04-28 Promega Corporation Luciferase biosensor
EP2004813B1 (en) 2006-04-03 2015-06-03 Promega Corporation Permuted and nonpermuted luciferase biosensors binding cyclic nucleotides
JP6110591B2 (ja) 2008-05-19 2017-04-05 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ ｃＡＭＰのためのルシフェラーゼバイオセンサー
WO2010127368A1 (en) * 2009-05-01 2010-11-04 Promega Corporation Synthetic oplophorus luciferases with enhanced light output
EP2990479B1 (en) 2010-05-11 2019-03-27 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
US9290794B2 (en) * 2010-05-11 2016-03-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
AU2011323455B2 (en) 2010-11-02 2017-07-27 Promega Corporation Coelenterazine derivatives and methods of using same
EP2782916B1 (en) 2011-11-21 2018-02-28 Promega Corporation Carboxy x rhodamine analogs
BR112015013715A2 (pt) 2012-12-12 2017-09-26 Promega Corp sistema, método para capturar o alvo celular, lisado celular e ligante de captura.
US10067149B2 (en) 2012-12-12 2018-09-04 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
BR112015013710B1 (pt) 2012-12-12 2022-08-09 Promega Corporation Métodos in vitro para detectar uma interação entre um agente bioativo e um alvo celular
JP6511720B2 (ja) * 2013-02-28 2019-05-15 Jnc株式会社 コドン最適化変異エビルシフェラーゼ遺伝子およびその使用方法
US10168323B2 (en) 2013-03-15 2019-01-01 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
US11072811B2 (en) 2013-03-15 2021-07-27 Promega Corporation Substrates for covalent tethering of proteins to functional groups or solid surfaces
AU2014236949C1 (en) * 2013-03-15 2018-11-29 Promega Corporation Activation of bioluminescence by structural complementation
JP2016517687A (ja) * 2013-03-27 2016-06-20 サンプル テクノロジーズ，インコーポレイティド 組換えファージ及び細菌検出方法
JP6040846B2 (ja) * 2013-04-08 2016-12-07 Jnc株式会社 セレンテラジン類縁体
CA2915820A1 (en) 2013-06-19 2014-12-24 Michael Sandor Koeris Phage-based bacterial detection assay
CN116004721A (zh) * 2013-07-12 2023-04-25 费城儿童医院 Aav载体和用于抗aav（腺相关病毒）中和抗体的检测
AU2013394649B2 (en) 2013-07-18 2020-07-16 Ecole Polytechnique Federale De Lausanne (Epfl) Means and methods for bioluminescence resonance energy transfer (BRET) analysis in a biological sample
JP6484987B2 (ja) 2013-10-21 2019-03-20 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
WO2015067302A1 (en) 2013-11-05 2015-05-14 Ecole Polytechnique Federale De Lausanne (Epfl) Sensor molecules and uses thereof
JP6442825B2 (ja) 2013-12-26 2018-12-26 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
EP3099683B1 (en) 2014-01-29 2020-08-05 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
JP6588917B2 (ja) 2014-01-29 2019-10-09 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 生細胞への適用のためのプロ基質
JP6256118B2 (ja) 2014-03-11 2018-01-10 Jnc株式会社 エビルシフェラーゼの触媒蛋白質のキメラ遺伝子及びその使用法
JP6265020B2 (ja) 2014-04-16 2018-01-24 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
EP3146066B1 (en) * 2014-05-23 2018-03-14 Promega Corporation Compositions and methods for stabilizing luminogenic substrates
US9732373B2 (en) 2014-09-11 2017-08-15 Promega Corporation Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence
US11365402B2 (en) * 2014-09-12 2022-06-21 Promega Corporation Internal protein tags
EP4219736A1 (en) * 2014-09-12 2023-08-02 Promega Corporation Internal protein tags
US20190054117A1 (en) * 2014-12-19 2019-02-21 Novartis Ag Dimerization switches and uses thereof
EP3254113B1 (en) 2015-02-05 2024-10-09 Promega Corporation Luciferase-based thermal shift assays
JP6876002B2 (ja) 2015-06-05 2021-05-26 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 機能的要素を共有結合により係留させるための細胞透過性、細胞適合性、かつ開裂可能であるリンカー
EP3313846B1 (en) 2015-06-25 2020-05-06 Promega Corporation Thienopyrrole compounds and uses thereof as inhibitors of oplophorus-derived luciferases
US20170029798A1 (en) * 2015-07-27 2017-02-02 Cellivery Therapeutics, Inc. Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)
US9924073B2 (en) 2016-02-15 2018-03-20 Promega Corporation Substituted imidazo[1,2-a]pyrazines as luciferase substrates and preparation method thereof
WO2017155036A1 (ja) 2016-03-11 2017-09-14 国立研究開発法人産業技術総合研究所 発光酵素タンパク質
US10634680B2 (en) 2016-04-26 2020-04-28 University Of Utah Research Foundation Target-binding activated split reporter systems for analyte detection and related components and methods
CN105968114B (zh) * 2016-05-27 2018-11-09 山东大学 一种腔肠素类似物及其制备方法与应用
DK3490991T3 (da) 2016-07-28 2021-01-25 Promega Corp Coelenterazine analogues
US10202584B2 (en) * 2016-09-01 2019-02-12 The Regents Of The University Of California Red-shifted luciferase-luciferin pairs for enhanced bioluminescence
EP3510035B1 (en) 2016-09-09 2021-04-07 Promega Corporation Dual protected pro-coelenterazine substrates
EP4144738A1 (en) 2016-11-01 2023-03-08 Promega Corporation Coelenterazine analogues tethered to energy acceptors
DK3548492T5 (en) 2016-12-01 2024-08-05 Promega Corp Cell impermeable coelenterazine analogues
EP3548470B1 (en) * 2016-12-01 2023-11-01 Promega Corporation 5,5-disubstituted luciferins and their use in luciferase-based assays
EP3562823B1 (en) 2016-12-28 2023-02-08 Promega Corporation Functionalized nanoluc inhibitors
EP3395803A1 (en) 2017-04-28 2018-10-31 Institut Pasteur Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins
WO2018219953A1 (en) 2017-05-30 2018-12-06 Ecole polytechnique fédérale de Lausanne (EPFL) Sensors, methods and kits for detecting nadph based on resonance energy transfer.
WO2019010094A1 (en) * 2017-07-06 2019-01-10 Promega Corporation STERILE SERIES PRO-COELENTERAZINE ANALOGS
CN108107209B (zh) * 2017-09-19 2020-07-24 中国中医科学院医学实验中心 一种检测分泌型报告蛋白含量的优化方法及其所用生物材料
JP7419260B2 (ja) * 2018-05-01 2024-01-22 プロメガ コーポレイション ＮａｎｏＬｕｃ自殺基質としてのセレンテラジン化合物
EP3803401A4 (en) 2018-05-30 2022-02-23 Promega Corporation BROAD SPECTRUM KINASE BINDERS
EP3802514B1 (en) 2018-06-01 2022-08-03 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes
WO2019241438A2 (en) * 2018-06-12 2019-12-19 Promega Corporation Multipartite luciferase
US10962538B2 (en) 2018-06-14 2021-03-30 The Trustees Of Columbia University In The City Of New York Assays using arrestin recruitment and unmodified receptors
US11857638B2 (en) 2018-07-27 2024-01-02 Promega Corporation Quinone-containing conjugates
CN112513188B (zh) * 2018-08-23 2024-01-26 普洛麦格公司 腔肠素类似物
US11534504B2 (en) 2018-10-03 2022-12-27 Promega Corporation Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof
US11175228B2 (en) 2018-11-28 2021-11-16 Promega Corporation Reactive peptide labeling
WO2020117954A2 (en) 2018-12-04 2020-06-11 Promega Corporation Broad spectrum gpcr binding agents
US20220259574A1 (en) * 2019-02-27 2022-08-18 University Of Virginia Patent Foundation Atp-independent bioluminescent reporter variants to improve in vivo imaging
WO2020191339A1 (en) 2019-03-20 2020-09-24 Promega Corporation Photoaffinity probes
US11360096B2 (en) 2019-05-16 2022-06-14 Duke University Complex BRET technique for measuring biological interactions
JP7650829B2 (ja) 2019-06-24 2025-03-25 プロメガ コーポレイション 細胞中に生体分子を送達するための修飾ポリアミンポリマー
US12241839B2 (en) 2019-11-27 2025-03-04 Promega Corporation Multipartite luciferase peptides and polypeptides
JP7745550B2 (ja) 2019-12-10 2025-09-29 プロメガ コーポレイション 多官能性プローブを使用する生物発光検出用組成物及び生物発光検出方法
WO2021187531A1 (ja) * 2020-03-17 2021-09-23 国立研究開発法人産業技術総合研究所 発光基質化合物
EP3882632A1 (en) 2020-03-18 2021-09-22 Universite De Bordeaux Novel ion conducting channel fusion subunits and methods of use thereof
CN113527231A (zh) * 2020-04-15 2021-10-22 深圳华大生命科学研究院 杂环取代腔肠素类化合物的合成方法
EP3904508A1 (en) * 2020-04-27 2021-11-03 Institut Pasteur Luciferase linked immunosorbent assay
JP7677997B2 (ja) 2020-05-22 2025-05-15 プロメガ コーポレイション キナーゼターゲットエンゲージメントの増強
WO2022047186A1 (en) 2020-08-28 2022-03-03 Promega Corporation Target engagement assay for ras proteins
EP4257978A4 (en) 2020-12-25 2024-11-13 Chugai Seiyaku Kabushiki Kaisha METHOD FOR SCREENING CANDIDATE MOLECULES CAPABLE OF FORMING A COMPLEX IN CONJUNCTION WITH MULTIPLE TARGET MOLECULES
CN115161296B (zh) * 2021-04-01 2024-08-13 深圳华大生命科学研究院 一种刺虾荧光素酶Nluc的突变体及其应用
AU2022333242A1 (en) * 2021-08-24 2024-03-07 Centre National De La Recherche Scientifique Luminescent based antigen assay
WO2023215432A1 (en) 2022-05-04 2023-11-09 Promega Corporation Circularly permuted dehalogenase variants
EP4519385A2 (en) 2022-05-04 2025-03-12 Promega Corporation Bioluminescence-triggered photocatalytic labeling
EP4519425A1 (en) 2022-05-04 2025-03-12 Promega Corporation Modified dehalogenase with extended surface loop regions
WO2023215452A2 (en) 2022-05-04 2023-11-09 Promega Corporation Split modified dehalogenase variants
EP4549570A1 (en) * 2022-06-30 2025-05-07 DGI Tech (Qing Dao) Co., Limited Luciferase mutant and use thereof
CN115349611B (zh) * 2022-08-05 2023-10-24 江南大学 一种改善南美白对虾虾糜凝胶品质的方法
CN116068198B (zh) * 2022-11-30 2024-01-09 深圳湾实验室 Ppi原位检测方法及其载体、诊断试剂、试剂盒和应用
EP4689615A2 (en) * 2023-03-24 2026-02-11 Promega Corporation Bioluminescence-triggered photocatalytic activation
JP7482563B1 (ja) 2023-06-21 2024-05-14 国立大学法人大阪大学 シイノトモシビタケ由来の発光関連遺伝子
DE102023120682B3 (de) 2023-08-03 2024-10-24 Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut Zytotoxizitätstest zum Nachweis von Zellschäden
GB202404021D0 (en) 2024-03-20 2024-05-01 Ipsen Biopharm Ltd Cell-based neurotoxin assay

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0134108B1 (en) 1983-08-17 1989-04-05 AlliedSignal Inc. Gas generator and method of generating gas
JPH0515398A (ja) 1991-07-15 1993-01-26 Nippon Oil & Fats Co Ltd オキシダーゼ酵素の定量方法
US5368484A (en) 1992-05-22 1994-11-29 Atari Games Corp. Vehicle simulator with realistic operating feedback
US6387675B1 (en) 1994-01-03 2002-05-14 Promega Corporation Mutant luciferases
ATE391769T1 (de) 1994-01-03 2008-04-15 Promega Corp Mutierte luziferasen
GB9501170D0 (en) 1994-03-23 1995-03-08 Secr Defence Luciferases
JP3648763B2 (ja) 1994-08-23 2005-05-18 日本油脂株式会社 ウミホタルルシフェリン誘導体および糖加水分解酵素の定量方法
GB9417593D0 (en) 1994-09-01 1994-10-19 Secr Defence Luciferase labelling method
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
AU707243B2 (en) 1995-01-20 1999-07-08 Promega Corporation Mutant luciferases
JPH08294397A (ja) 1995-04-27 1996-11-12 Nippon Oil & Fats Co Ltd 免疫学的活性物質の測定方法
US5998204A (en) 1997-03-14 1999-12-07 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
GB9707486D0 (en) 1997-04-11 1997-05-28 Secr Defence Enzyme assays
CA2285571C (en) 1997-04-16 2008-12-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Immunomodulatory molecules and process for producing the same
AU754312C (en) * 1997-09-19 2005-11-10 Promega Corporation Thermostable luciferases and methods of production
US6602677B1 (en) 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
JP3694181B2 (ja) * 1999-01-05 2005-09-14 キッコーマン株式会社 変異型ルシフェラーゼ、変異型ルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ルシフェラーゼの製造法
CN100516223C (zh) * 1999-10-26 2009-07-22 3M创新有限公司 新型酶
GB9925161D0 (en) 1999-10-26 1999-12-22 Secr Defence Novel enzyme
US20010046687A1 (en) 2000-03-31 2001-11-29 Dicesare Joseph L. Method for the enhancement of luminescence intensity from a reaction between adenosine triphosphate (ATP) and a luciferase/luciferin reactant system
DE60142761D1 (de) 2000-04-26 2010-09-23 Chisso Corp Oplophorus Luciferase
JP4613441B2 (ja) * 2000-04-26 2011-01-19 チッソ株式会社 新規ルシフェラーゼおよび発光蛋白質
US7118878B1 (en) 2000-06-09 2006-10-10 Promega Corporation Method for increasing luminescence assay sensitivity
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
US7268229B2 (en) 2001-11-02 2007-09-11 Promega Corporation Compounds to co-localize luminophores with luminescent proteins
US7148030B2 (en) 2002-02-01 2006-12-12 Promega Corporation Bioluminescent protease assay
CA2497560A1 (en) 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
ATE290016T1 (de) * 2002-10-21 2005-03-15 Axxam S R L Photoprotein mit verbesserter biolumineszenz
AU2003300008B2 (en) 2002-12-23 2007-04-05 Promega Corporation Improved luciferase-based assays
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
EP2455457B1 (en) 2003-01-31 2015-03-11 Promega Corporation Covalent tethering of functional groups to proteins
EP1592805A1 (en) 2003-02-12 2005-11-09 Promega Corporation Methods and kits for dual enzymatic assays whereby light is quenched from luminescent reactions
US20040178545A1 (en) 2003-03-14 2004-09-16 Cates Larry E. System for optically analyzing a molten metal bath
WO2005038029A2 (en) 2003-10-10 2005-04-28 Promega Corporation Luciferase biosensor
CA2552916C (en) 2004-01-08 2014-11-18 Universitat Zurich Metal complexes having vitamin b12 as a ligand
US7553632B2 (en) 2004-01-22 2009-06-30 Promega Corporation Luminogenic and nonluminogenic multiplex assay
US7416854B2 (en) 2004-01-22 2008-08-26 Promega Corporation Luminogenic and nonluminogenic multiplex assay
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
US20070087400A1 (en) 2004-07-30 2007-04-19 Aldis Darzins Covalent tethering of functional groups to proteins and substrates therefor
EP3179252B1 (en) 2004-07-30 2018-11-14 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
US7728118B2 (en) 2004-09-17 2010-06-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
JP4639904B2 (ja) 2005-03-30 2011-02-23 チッソ株式会社 蛍光活性を有するルシフェラーゼの活性増強方法
JP3844082B2 (ja) * 2005-04-08 2006-11-08 キッコーマン株式会社 耐熱性ホタルルシフェラーゼ、耐熱性ホタルルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ及び耐熱性ホタルルシフェラーゼの製造法
EP1935986B1 (en) 2005-05-31 2014-04-16 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
EP1885875B1 (en) 2005-05-31 2019-05-22 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
US7495579B2 (en) 2005-06-13 2009-02-24 Sirota J Marcos Traffic light status remote sensor system
CA2616930A1 (en) 2005-08-17 2007-02-22 Yeda Research And Development Co. Ltd. Methods and compositions for determining a level of biologically active serum paraoxonase
JP4999341B2 (ja) 2005-09-06 2012-08-15 株式会社バイオエネックス 変異型ホタルルシフェラーゼ、遺伝子、組換えベクター、形質転換体、及び変異型ホタルルシフェラーゼの製造方法
EP2004813B1 (en) 2006-04-03 2015-06-03 Promega Corporation Permuted and nonpermuted luciferase biosensors binding cyclic nucleotides
JP2007306871A (ja) 2006-05-19 2007-11-29 Chisso Corp 封入体可溶化方法及び精製方法
WO2008054821A2 (en) 2006-10-30 2008-05-08 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and functional expression
WO2008086035A2 (en) 2007-01-10 2008-07-17 Promega Corporation Split mutant hydrolase fusion reporter and uses thereof
WO2008118445A1 (en) 2007-03-26 2008-10-02 Promega Corporation Methods to quench light from optical reactions
US20090253131A1 (en) 2007-11-05 2009-10-08 Promega Corporation Hybrid fusion reporter and uses thereof
JP6110591B2 (ja) 2008-05-19 2017-04-05 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ ｃＡＭＰのためのルシフェラーゼバイオセンサー
JP5753083B2 (ja) 2008-07-22 2015-07-22 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ Ａｄｐ検出に基づく発光ホスホトランスフェラーゼまたはａｔｐヒドロラーゼのアッセイ法
TWI375901B (en) 2008-08-05 2012-11-01 Elan Microelectronics Corp Touch screen and method for positioning coordinate
JP5582505B2 (ja) * 2009-02-09 2014-09-03 Ｊｎｃ株式会社 セレンテラジン類縁体及びその製造方法
WO2010119721A1 (ja) * 2009-04-17 2010-10-21 独立行政法人産業技術総合研究所 超高輝度で安定な人工生物発光酵素
WO2010127368A1 (en) 2009-05-01 2010-11-04 Promega Corporation Synthetic oplophorus luciferases with enhanced light output
WO2011038219A1 (en) 2009-09-24 2011-03-31 Promega Corporation Proteases having improved stability, solubility and activity
JP5605727B2 (ja) * 2010-04-06 2014-10-15 Ｊｎｃ株式会社 セレンテラジン類縁体及びセレンテラミド類縁体
EP2990479B1 (en) 2010-05-11 2019-03-27 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
WO2012030960A1 (en) 2010-09-01 2012-03-08 Promega Corporation Oxidized glutathione assay
US9284188B2 (en) 2010-09-03 2016-03-15 The Regents Of The University Of California Cytosolic delivery of materials with endosome-disrupting colloids
SG10202103336SA (en) 2010-11-02 2021-04-29 Promega Corp Novel coelenterazine substrates and methods of use
AU2011323455B2 (en) * 2010-11-02 2017-07-27 Promega Corporation Coelenterazine derivatives and methods of using same
US9273343B2 (en) 2011-09-02 2016-03-01 Promega Corporation Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018127459A (ja) * 2010-11-02 2018-08-16 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 新規セレンテラジン基質及び使用法

Also Published As

Publication number Publication date
BR112013010855A2 (pt) 2017-06-27
JP2017176182A (ja) 2017-10-05
EP3498709A1 (en) 2019-06-19
JP6374420B2 (ja) 2018-08-15
IL225867B (en) 2018-07-31
SG189496A1 (en) 2013-05-31
CN106148362B (zh) 2021-04-30
WO2012061530A3 (en) 2012-09-27
IL288070A (en) 2022-01-01
AU2011323418B2 (en) 2017-07-27
BR112013010487B1 (pt) 2021-02-02
KR20130099997A (ko) 2013-09-06
CA2815227C (en) 2019-03-26
US20240158831A1 (en) 2024-05-16
US9139836B2 (en) 2015-09-22
US11661623B2 (en) 2023-05-30
US9840730B2 (en) 2017-12-12
PL2635595T4 (pl) 2019-04-30
IL288070B2 (en) 2023-02-01
US8669103B2 (en) 2014-03-11
CA2815227A1 (en) 2012-05-10
CN106148362A (zh) 2016-11-23
ES2567410T3 (es) 2016-04-22
US12215375B2 (en) 2025-02-04
PL2635595T3 (pl) 2019-04-30
EP2635595B1 (en) 2019-01-09
CA2817102A1 (en) 2012-05-10
US20160002703A1 (en) 2016-01-07
JP2014503485A (ja) 2014-02-13
JP2016145219A (ja) 2016-08-12
AU2016213854A1 (en) 2016-09-01
SG190104A1 (en) 2013-06-28
US20120117667A1 (en) 2012-05-10
US20220348983A1 (en) 2022-11-03
US20260028662A1 (en) 2026-01-29
EP2635595A2 (en) 2013-09-11
JP6752839B2 (ja) 2020-09-09
KR101939553B1 (ko) 2019-01-17
US10774364B2 (en) 2020-09-15
EP2635582A1 (en) 2013-09-11
CN103370319A (zh) 2013-10-23
AU2016213854B2 (en) 2018-01-04
JP2014500011A (ja) 2014-01-09
IL274316A (en) 2020-06-30
CA3081115A1 (en) 2012-05-10
US8809529B2 (en) 2014-08-19
US12435354B2 (en) 2025-10-07
CN103443121A (zh) 2013-12-11
KR20130084312A (ko) 2013-07-24
BR112013010487A2 (pt) 2016-11-22
IL274316B (en) 2021-12-01
JP2016144454A (ja) 2016-08-12
EP3498709C0 (en) 2025-12-31
IL226114B (en) 2018-04-30
US20200399676A1 (en) 2020-12-24
US20180327810A1 (en) 2018-11-15
SG10201607774RA (en) 2016-11-29
US9938564B2 (en) 2018-04-10
SG10201608550SA (en) 2016-12-29
US9951373B2 (en) 2018-04-24
EP3498709B1 (en) 2025-12-31
PL2635582T3 (pl) 2016-08-31
WO2012061530A8 (en) 2013-06-06
US20140223590A1 (en) 2014-08-07
JP6574721B2 (ja) 2019-09-11
AU2011323418A1 (en) 2013-05-30
SG10202103336SA (en) 2021-04-29
IL225867A0 (en) 2013-07-31
JP6539689B2 (ja) 2019-07-03
EP2635582B1 (en) 2016-01-27
IL258790A (en) 2018-06-28
AU2011323419A1 (en) 2013-05-30
ES2723773T3 (es) 2019-09-02
IL288070B (en) 2022-10-01
KR101538624B1 (ko) 2015-07-22
PT2635595T (pt) 2019-01-29
DK2635595T3 (en) 2019-03-04
WO2012061530A2 (en) 2012-05-10
JP2018127459A (ja) 2018-08-16
US20150064731A1 (en) 2015-03-05
DK2635582T3 (da) 2016-03-14
CN103370319B (zh) 2016-08-24
IL258790B (en) 2020-05-31
JP6155424B2 (ja) 2017-07-05
US20120174242A1 (en) 2012-07-05
EP3498710A1 (en) 2019-06-19
IL226114A0 (en) 2013-06-27
US20140227759A1 (en) 2014-08-14
CN103443121B (zh) 2016-04-20
CA2817102C (en) 2020-07-28
WO2012061529A1 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
JP6574721B2 (ja) 新規セレンテラジン基質及び使用法
AU2011323419B2 (en) Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150715

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150716

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20151008

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20151113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151215

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160118

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160217

R150 Certificate of patent or registration of utility model

Ref document number: 5889910

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250